Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Tetragon Partners GP Ltd
Form 13F · Q2 2026

Tetragon Partners GP Ltd

CIK 1515070申报日 2026-08-1313F-HR 在 EDGAR 查看原始申报 ↗
$6.4亿
申报组合市值
43
持仓数量
12
Quarters on record
Top 50
持仓数量

Tetragon Partners GP Ltd——持仓

共 43 个持仓中的前 32 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1PATH Uipath Inc30.9M+22.8%$3.4亿53.0%
2KGEI Kolibri Global Energy Inc6.8M+0.0%$3385万5.3%
3AUTL Autolus Therapeutics Ltd9.5M+0.0%$1520万2.4%
4LYFT Lyft Inc1.0M+0.0%$1461万2.3%
5DFTX Definium Therapeutics Inc286,990+43.5%$1350万2.1%
6WK Workiva Inc250,000+0.0%$1213万1.9%
7CXM Sprinklr Inc2.2M+0.0%$1135万1.8%
8MBX Mbx Biosciences Inc203,543+39.9%$1124万1.8%
9ALKT Alkami Technology Inc600,284—$1088万1.7%
10CLDX Celldex Therapeutics Inc New290,441−7.0%$1081万1.7%
11RLAY Relay Therapeutics Inc570,311+214.1%$1067万1.7%
12ARWR Arrowhead Pharmaceuticals In130,484+2.6%$1064万1.7%
13PHVS Pharvaris N V295,627+33.4%$1022万1.6%
14ALKS Alkermes Plc189,979+18.9%$995万1.6%
15IMVT Immunovant Inc255,934+17.1%$986万1.6%
16SLN Silence Therapeutics Plc764,256+21.3%$839万1.3%
17DYN Dyne Therapeutics Inc356,657+38.2%$792万1.2%
18IONS Ionis Pharmaceuticals Inc97,173+132.7%$770万1.2%
19AGIO Agios Pharmaceuticals Inc205,579+24.7%$763万1.2%
20HRMY Harmony Biosciences Hldgs In201,036+68.5%$732万1.2%
21KRYS Krystal Biotech Inc19,668+0.0%$731万1.2%
22ANNX Annexon Inc1.2M−3.9%$709万1.1%
23CELC Celcuity Inc64,110—$671万1.1%
24WARNER BROS DISCOVERY INC Warner Bros Discovery Inc250,000−72.9%$666万1.0%
25NKTR Nektar Therapeutics86,996−15.6%$607万1.0%
26AMLX Amylyx Pharmaceuticals Inc297,926−6.3%$535万0.8%
27ACAD Acadia Pharmaceuticals Inc167,875+16.1%$425万0.7%
28CUE Cue Biopharma Inc93,819—$296万0.5%
29SNOW Snowflake Inc10,000+0.0%$254万0.4%
30ACRS Aclaris Therapeutics Inc400,000—$212万0.3%
31TECX Tectonic Therapeutic Inc46,516+23.8%$160万0.3%
32GLUE Monte Rosa Therapeutics Inc56,052—$136万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。